BiotechTube
Home/Alterity Therapeutics/Geoffrey Kempler
GK

Geoffrey Kempler

Non-Executive Chairman

Alterity Therapeutics

Therapeutic Areas

NeuroscienceNeurodegenerative Diseases

Alterity Therapeutics Pipeline

DrugIndicationPhase
ATH434Multiple System Atrophy (MSA)Phase 2

Leadership Team at Alterity Therapeutics

DS
David Stamler, M.D.
Chief Executive Officer
DA
Dr. Andrew S. L. Chan
Chief Scientific Officer
TC
Thomas C. Scanlin, Ph.D.
Chief Medical Officer
View full Alterity Therapeutics profile